Evidence map›Paper›PMID 41564243›Full record

ReviewJournal of medicinal chemistry2026

Metabolic Stability of Fluorinated Small Molecules: A Physical Organic Chemistry Perspective.

Pankaj Bhattarai, Trevor A Trombley, Ryan A Altman

Abstract readReview
In one paragraph

Review in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Direct Regioselective para-Fluorination via I(I)/I(III) Catalysis.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. A Ni-Mediated Cross-Coupling Approach to DeuteratedJournal of the American Chemical Society · 2026
    Article
  6. Discovery ofJournal of medicinal chemistry · 2026
    Article
  7. Article
  8. Article
  9. The Effect ofACS medicinal chemistry letters · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pankaj BhattaraiBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-5606-464X
Trevor A TrombleyJames Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0003-0413-0913
Ryan A AltmanBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-8724-1098

Funding

Grant Supplement to Support Diversity in Health-Related ResearchR35GM124661 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Ryan A Altman · 2017 to 2026
$4.1M
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative DiseaseF31AG084329 · NIA · PURDUE UNIVERSITY · PI Trevor Trombley · 2023 to 2026
$147k
NIA NIH HHS F31 AG084329NIGMS NIH HHS R35 GM124661
6 · The paper itself

Abstract

The incorporation of fluorine and fluorinated motifs into medicinally relevant scaffolds can improve the metabolic and pharmacokinetic properties (DMPK) of drug molecules. Typically, this phenomenon is attributed to differences in C-H vs C-F bond strengths, though such an explanation ignores accepted mechanisms of drug metabolism and how fluorine and fluorinated substituents perturb the physicochemical properties of small molecules. Instead of relying on bond strengths, this perspective will review established mechanisms of drug metabolism and provide a mechanistic rationale for the improved metabolic profiles achieved by fluorinating drug candidates. This discussion will connect observed trends in structure-metabolism relationships with known mechanistic features of relevant drug-metabolizing enzymes, with the ultimate goal of improving medicinal chemistry decision-making.

Indexed as

FluorineAnimalsHalogenationHumansPharmaceutical PreparationsStructure-Activity RelationshipFluorinePharmaceutical Preparations

Identifiers

PMID41564243
PMCPMC12826311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.